Quarterly Result11 May 2026, 09:11 pm
JB Pharma FY26: Revenue ₹4,148 Cr, PAT ₹709 Cr
AI Summary
JB Chemicals & Pharmaceuticals Ltd announced its FY26 results. Revenue reached ₹4,148 crores, a 6% YoY increase. Net profit after tax stood at ₹709 crores, up 8% YoY. Q4 FY26 revenue was ₹904 crores, with a net profit of ₹101 crores. The company experienced a muted performance in Q4 due to operational resets and integration activities following a change of control, but expects recovery in H1. India business grew by 9% for FY26, while international formulations saw a 2% increase.
Key Highlights
- FY26 revenue grew 6% YoY to ₹4,148 crores.
- FY26 net profit after tax increased 8% YoY to ₹709 crores.
- Q4 FY26 revenue was ₹904 crores, with EBITDA at ₹241 crores.
- India business grew 9% YoY for FY26, reaching ₹2,461 crores.
- Company expects improved performance in upcoming quarters following integration activities.